FIGURE D. PRIMARY ANTIMICROBIAL DRUG USED TO TREAT GONORRHEA AMONG GISP PARTICIPANTS, 2019
| CLINIC | Percentage | ||||||
|---|---|---|---|---|---|---|---|
| None | Ceftriaxone 250 mg | Ceftriaxone 125 mg | Cefixime | Azithromycin 2gm | Gentamicin | Other | |
| ALBUQUERQUE | . | 98.3 | . | . | 1.7 | . | . |
| ANCHORAGE | . | 94.8 | . | . | . | 5.2 | . |
| BALTIMORE | . | 100.0 | . | . | . | . | . |
| BIRMINGHAM | . | 95.1 | 1.0 | . | 3.9 | . | . |
| BUFFALO | . | 100.0 | . | . | . | . | . |
| CAMDEN | 7.1 | 81.0 | . | . | 11.9 | . | . |
| CHICAGO | . | 98.4 | . | . | . | 1.6 | . |
| CLEVELAND | . | 100.0 | . | . | . | . | . |
| COLUMBUS | 0.3 | 95.3 | . | . | . | 4.3 | . |
| DALLAS | 1.3 | 98.3 | . | . | . | 0.3 | . |
| DENVER | 0.3 | 97.9 | . | . | . | 1.7 | . |
| GREENSBORO | 0.5 | 96.3 | . | . | . | 3.2 | . |
| HONOLULU | . | 98.4 | 1.6 | . | . | . | . |
| INDIANAPOLIS | 2.4 | 93.9 | . | 2.7 | . | 1.0 | . |
| JACKSON | 3.3 | 92.4 | . | . | 4.3 | . | . |
| KANSAS CITY | 0.7 | 98.3 | . | . | . | 1.0 | . |
| LAS VEGAS | . | 99.2 | . | . | . | 0.8 | . |
| LOS ANGELES | . | 98.7 | . | . | . | 1.3 | . |
| MIAMI | . | 100.0 | . | . | . | . | . |
| MILWAUKEE | . | 98.9 | . | . | . | 1.1 | . |
| MINNEAPOLIS | . | 97.6 | . | . | . | 2.4 | . |
| NEW ORLEANS | . | 91.7 | . | . | . | 3.3 | 5.0 |
| NEW YORK CITY | . | 95.1 | . | . | . | 4.5 | 0.4 |
| ORANGE COUNTY | 0.6 | 96.8 | . | . | . | 2.6 | . |
| PHILADELPHIA | 1.7 | 97.7 | . | . | . | 0.7 | . |
| PHOENIX | 0.3 | 98.7 | . | . | 0.7 | 0.3 | . |
| PONTIAC | 1.5 | 96.9 | . | . | 1.5 | . | . |
| PORTLAND | . | 95.2 | . | . | . | 2.4 | 2.4 |
| SAN DIEGO | . | 96.2 | . | . | . | 3.8 | . |
| SAN FRANCISCO | . | 98.8 | . | 1.2 | . | . | . |
| SEATTLE | 1.8 | 95.6 | . | . | . | 2.6 | . |
| TRIPLER | . | 100.0 | . | . | . | . | . |
| WASHINGTON DC | 2.6 | 97.4 | . | . | . | . | . |
Page last reviewed: June 30, 2021